AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks rally, crude prices fall
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
Amgen (AMGN) Tops Q2 EPS by 69c, Beats on Revenue; Offers FY26 Guidance
August 4, 2026 4:04 PM EDTAmgen (NASDAQ: AMGN) reported Q2 EPS of $6.29, $0.69 better than the analyst estimate of $5.60. Revenue for the quarter came in at $10.1 billion versus the consensus estimate of $9.43 billion.
GUIDANCE:
Amgen sees FY2026 EPS of $22.30-$23.50, versus the consensus of $22.35. Amgen sees... More
